Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
Depending on the exchange, the stock ticker may vary. For instance, on exchange Coloplast AS stocks are traded under the ticker CBHD.MU.
When is the next Coloplast AS earnings date?▼
Coloplast AS is going to release the next earnings report on May 12, 2026.
What were Coloplast AS earnings last quarter?▼
CBHD.MU earnings for the last quarter are 0.84 EUR per share, whereas the estimation was 0.81 EUR resulting in a +3.46% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Coloplast AS have?▼
As of April 12, 2026, the company has 16,983 employees.
In which sector is Coloplast AS located?▼
Coloplast AS operates in the Health & Wellness sector.
When did Coloplast AS complete a stock split?▼
Coloplast AS has not had any recent stock splits.
Where is Coloplast AS headquartered?▼
Coloplast AS is headquartered in Humlebæk, Denmark.